Australian Statistics on Medicines 2011

Table 1 - Generic Antiinfectives for Systemic Use

GENERAL ANTIINFECTIVES FOR SYSTEMIC USE

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
J02 - ANTIMYCOTICS FOR SYSTEMIC USE
J04 - ANTIMYCOBACTERIALS
J05 - ANTIVIRALS FOR SYSTEMIC USE
J07 - VACCINES

J01 - ANTIBACTERIALS FOR SYSTEMIC USE
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE TETRACYCLINES TETRACYCLINES
J01AA02	DOXYCYCLINE
	A	18810	Capsule 100mg 7	0.10	GM	142	-
	P	2702F	Tablet 100mg (HCl salt after 1 Oct 2007) 28	0.10	GM	69,109	969,936
	P	2703G	Capsule 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	47,580	667,404
	P	2707L	Capsule 50mg (as HCl salt after 1 Oct 2007)	0.10	GM	261,401	2,617,307
	P	2708M	Capsule 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	274,132	2,373,449
	P	2709N	Tablet 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	267,509	2,353,294
	P	2711Q	Tablet 50mg (as HCl salt after 1 Oct 2007) 25	0.10	GM	237,551	2,388,587
	P	2714W	Tablet 100mg (as HCl salt after 1 Oct 2007) 21	0.10	GM	42,079	505,148
	P	2715X	Capsule 100mg (as HCl salt after 1 Oct 2007)	0.10	GM	42,569	516,608
	P	3321T	Tablet 100mg	0.10	GM	1,359	11,351
	P	3322W	Capsule 100mg	0.10	GM	551	4,602
	P	5082L	Tablet 100mg (monohydrate) 7	0.10	GM	8,039	67,201
	P	9105F	Tablet 100mg (monohydrate) 7	0.10	GM	157,068	1,323,223
	P	9106G	Tablet 50mg (as monohydrate) 25	0.10	GM	215,207	2,135,908
	P	9107H	Tablet 100mg (monohydrate) 28	0.10	GM	30,949	432,929
	P	9108J	Tablet 100mg (as monohydrate) 21	0.10	GM	17,848	215,455
J01AA08	MINOCYCLINE
	P	1616C	Tablet 50mg	0.20	GM	375,942	5,649,836
	P	3037W	Capsule 100mg	0.20	GM	2,726	20,772
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
PENICILLINS WITH EXTENDED SPECTRUM
J01CA04	AMOXYCILLIN
	P	1878W	Sachet containing oral powder 3g	1.00	GM	13,230	125,991
	P	1884E	Capsule 250mg	1.00	GM	324,160	2,767,974
	P	1886G	Powder for syrup 125mg per 5mL 100mL	1.00	GM	601,956	6,492,721
	P	1887H	Powder for syrup 250mg per 5mL 100mL	1.00	GM	1,117,188	12,986,280
	P	1888J	Powder paediatric oral drops 100mg per mL 20mL	1.00	GM	210,519	2,782,081
	P	1889K	Capsule 500mg	1.00	GM	3,226,606	34,158,818
	P	3300Q	Capsule 500mg	1.00	GM	478,202	4,976,019
	P	3301R	Capsule 250mg	1.00	GM	40,044	338,221
	P	3302T	Powder for syrup 125mg per 5mL 100mL	1.00	GM	9,725	104,921
	P	3309E	Sachet containing oral powder 3g	1.00	GM	23,228	208,547
	P	3393N	Powder for syrup 250mg per 5mL 100mL	1.00	GM	8,039	93,146
	P	5225B	Powder for oral suspension 500mg per 5mL 100mL	1.00	GM	226	3,264
	P	8581P	Tablet 1g 14	1.00	GM	166,347	1,769,181
	P	8705E	Powder for oral suspension 500mg per 5mL 100mL	1.00	GM	42,696	622,590
	P	9714G	Powder paediatric oral drops 100mg per mL 20mL	1.00	GM	337	2,797
J01CA01	AMPICILLIN
	P	2390T	Injection 500mg (solvent required)	2.00	GM	154	1,635
	P	2977Q	Injection 1g (solvent required)	2.00	GM	7,130	127,121
BETA-LACTAMASE SENSITIVE PENICILLINS
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
J01CE08	BENZATHINE PENICILLIN
	P	2267H	Injection 900mg in 2.3mL cartridge-needle unit	3.60	GM	1,887	498,088
J01CE10	BENZATHINE PHENOXYMETHYLPENICILLIN
	P	5012T	Oral suspension 150mg per 5mL 100mL	2.00	GM	230	4,187
	P	9143F	Oral suspension 150mg per 5mL 100mL	2.00	GM	150,708	3,179,461
J01CE01	BENZYLPENICILLIN
	P	1775K	Injection 600mg (solvent required)	3.60	GM	4,369	406,302
	P	2647H	Injection 3g (solvent required)	3.60	GM	1,512	154,203
	P	3486L	Injection 600mg (with sterilised water)	3.60	GM	2,011	74,308
	P	3487M	Injection 3g (solvent supplied)	3.60	GM	1,709	21,790
J01CE02	PHENOXYMETHYLPENICILLIN
	P	1703P	Tablet 250mg	2.00	GM	9,716	110,475
	P	1705R	Capsule 250mg	2.00	GM	28,862	322,375
	P	1787C	Tablet 250mg	2.00	GM	19,906	220,474
	P	1789E	Capsule 250mg	2.00	GM	26,100	289,681
	P	2965C	Capsule 500mg	2.00	GM	257,137	3,479,267
	P	3028J	Tablet 500mg	2.00	GM	112,408	1,500,770
	P	3360W	Tablet 250mg	2.00	GM	689	6,430
	P	3361X	Tablet 500mg	2.00	GM	2,868	29,685
	P	3363B	Capsule 250mg	2.00	GM	1,206	12,396
	P	3364C	Capsule 500mg	2.00	GM	6,730	78,328
	P	8976K	Powder for oral liquid 125mg (as potassium) per 5mL, 100mL 2	2.00	GM	1,527	24,043
	P	8977L	Powder for oral liquid 250mg (as potassium) per 5mL, 100mL 2	2.00	GM	5,888	107,532
J01CE09	PROCAINE PENICILLIN
	P	1794K	Injection 1.5g	0.60	GM	6,247	576,313
	P	3485K	Injection 1.5g	3.60	GM	19,257	1,774,134
BETA-LACTAMASE RESISTANT PENICILLINS
J01CF01	DICLOXACILLIN
	P	8121K	Capsule 250mg	2.00	GM	23,261	267,741
	P	8122L	Capsule 500mg	2.00	GM	293,180	5,491,987
J01CF05	FLUCLOXACILLIN
	P	1524F	Injection 500mg (solvent required)	2.00	GM	178	3,495
	P	1525G	Injection 1g (solvent required)	2.00	GM	14,578	745,116
	P	1526H	Capsule 250mg	2.00	GM	61,050	705,800
	P	1527J	Capsule 500mg	2.00	GM	421,024	7,849,229
	A	20345	Powder for syrup 250mg per 5mL 100mL	2.00	GM	168	-
	A	20436	Powder for syrup 250mg per 5mL 100mL	2.00	GM	208	-
	P	5091Y	Capsule 500mg	2.00	GM	283	4,595
	P	9149M	Powder for oral liquid 125mg per 5mL 100mL	2.00	GM	24,280	392,923
	P	9150N	Powder for oral liquid 250mg per 5mL 100mL	2.00	GM	53,073	1,178,172
COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS
J01CR02	AMOXYCILLIN with CLAVULANIC ACID
	P	1891M	Tablet 500mg-125mg	1.00	GM	483,302	5,839,410
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
	P	1892N	Powder for syrup 125mg-31.25mg per 5mL 75mL	1.00	GM	74,965	933,641
	P	5006L	Tablet 875mg-125mg	1.00	GM	69,866	991,919
	P	5008N	Tablet 500mg-125mg	1.00	GM	11,785	140,164
	P	5011R	Powder for syrup 400mg-57mg per 5mL 50mL	1.00	GM	250	3,426
	P	8254K	Tablet 875mg-125mg	1.00	GM	3,248,923	47,085,252
	P	8319W	Powder for syrup 400mg-57mg per 5mL 50mL	1.00	GM	502,172	7,277,634
J01CR03	TICARCILLIN with CLAVULANIC ACID
	P	2179Q	Injection 3g-100mg (solvent required)	15.00	GM	25,452	4,317,889
	P	6884H	Injection 3g-100mg 10mL and NS	15.00	GM	8,489	1,399,832
OTHER BETA-LACTAM ANTIBACTERIALS
FIRST-GENERATION CEPHALOSPORINS
J01DB01	CEFALEXIN
	A	20843	Capsule 250mg 20	2.00	GM	1,547	-
	P	3058Y	Capsule 250mg	2.00	GM	326,812	2,930,052
	P	3094W	Granules for syrup 125mg per 5mL 100mL	2.00	GM	157,600	1,850,234
	P	3095X	Granules for syrup 250mg per 5mL 100mL	2.00	GM	475,688	6,387,137
	P	3119E	Capsule 500mg	2.00	GM	4,131,708	44,259,027
	P	3317N	Capsule 250mg	2.00	GM	3,001	26,187
	P	3318P	Capsule 500mg	2.00	GM	24,389	257,108
	P	3320R	Granules for syrup 250mg per 5mL 100mL	2.00	GM	215	2,798
J01DB03	CEFALOTHIN
	P	2964B	Injection 1g (solvent required)	4.00	GM	20,138	488,345
J01DB04	CEPHAZOLIN
	P	1257E	Injection 1g (solvent required)	3.00	GM	14,978	871,632
	P	5478H	Powder for injection 1g 10	3.00	GM	22,520	1,139,995
	P	5479J	Powder for injection 2g 10	3.00	GM	832	91,495
	P	9326W	Powder for injection 2g 10	3.00	GM	726	122,922
SECOND-GENERATION CEPHALOSPORINS
J01DC04	CEFACLOR
	P	1169M	Tablet 375mg (sustained release)	1.00	GM	565,032	7,209,149
	P	2460L	Powder for oral susp 125mg per 5mL 100mL	1.00	GM	109,618	1,458,038
	P	2461M	Powder for oral susp 250mg per 5mL 75mL	1.00	GM	254,172	3,480,641
	P	5045M	Tablet 375mg (sustained release)	1.00	GM	430	5,390
J01DC02	CEFUROXIME
	P	8292K	Tablet 250mg 14	0.50	GM	117,985	2,288,367
THIRD-GENERATION CEPHALOSPORINS
J01DD01	CEFOTAXIME
	P	1085D	Injection 1g (solvent required)	4.00	GM	1,194	27,334
	P	1086E	Injection 2g (solvent required)	4.00	GM	284	11,501
J01DD04	CEFTRIAXONE
	P	1784X	Injection 1g (solvent required)	2.00	GM	49,014	1,722,862
	P	1785Y	Injection 2g (solvent required)	2.00	GM	6,172	387,864
	P	9058R	Injection 500mg (solvent required)	2.00	GM	2,457	25,194
OTHER BETA-LACTAM ANTIBACTERIALS
FOUTH-GENERATION CEPHALOSPORINS
J01DE01	CEFEPIME
	P	8315P	Injection 1g (solvent required)	2.00	GM	463	91,562
	P	8316Q	Injection 2g (solvent required)	2.00	GM	493	215,242
SULFONAMIDES AND TRIMETHOPRIM
TRIMETHOPRIM AND DERIVATIVES
J01EA01	TRIMETHOPRIM
	P	2922T	Tablet 300mg	0.40	GM	818,423	6,986,733
COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES
J01EE01	TRIMETHOPRIM with SULPHAMETHOXAZOLE
	P	2949F	Tablet 80mg-400mg	-	-	4,401	36,799
	P	2951H	Tablet 160mg-800mg	-	-	352,312	3,570,458
	P	3103H	Oral suspension 40mg-200mg per 5mL 100mL	-	-	113,266	1,036,517
	P	3390K	Tablet 160mg-800mg	-	-	821	7,575
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
J01FA10	AZITHROMYCIN
	A	19032	Tablet 500mg 3	0.30	GM	110,785	-
	A	20776	Tablet 500mg 3	0.30	GM	18,722	-
	A	21494	Tablet 500mg 3	0.30	GM	282	-
	P	4115N	Tablet 500mg	0.30	GM	10,332	505,825
	P	6221K	Tablet 600mg 16	0.30	GM	252	14,773
	P	8200N	Tablet 500mg	0.30	GM	63,310	1,348,144
	P	8201P	Powder for oral suspension 200mg per 5mL 15mL	0.30	GM	11,635	248,771
	P	8336R	Tablet 500mg 2	0.30	GM	70,901	1,483,631
J01FA09	CLARITHROMYCIN
	P	6151R	Tablet 250mg 100	0.50	GM	274	11,893
	P	6152T	Tablet 500mg 100	0.50	GM	352	25,823
	P	8318T	Tablet 250mg 14	0.50	GM	1,086,817	13,802,295
	P	9192T	Powder for oral liquid 250mg per 5mL 50mL	0.50	GM	54,143	1,988,345
J01FA01	ERYTHROMYCIN
	P	1397M	I.V. infusion 1g (base)	1.00	GM	793	66,721
	P	1404X	Capsule 250mg	1.00	GM	176,131	1,692,223
	P	2424N	Granules for paediatric oral susp 200mg	1.00	GM	202,961	2,507,452
	P	2428T	Granules for oral susp 400mg (base) per 5mL 10	1.00	GM	238,354	3,208,986
	P	2750R	Tablet 400mg (base)	1.00	GM	484,646	5,313,899
	P	3325B	Capsule 250mg	1.00	GM	12,317	114,309
	P	3334L	Granules for paediatric oral suspension 200mg	1.00	GM	367	4,479
	P	3336N	Tablet 400mg (base)	1.00	GM	5,807	61,810
	P	3337P	Granules for oral suspension 400mg(base) per 5mL	1.00	GM	260	3,484
J01FA06	ROXITHROMYCIN
	P	1760P	Tablet 150mg 10	0.30	GM	912,765	10,667,189
	P	5260W	Tablet 150mg 10	0.30	GM	658	7,559
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
	P	5261X	Tablet 300mg 5	0.30	GM	751	8,624
	P	8016X	Tablet 300mg 5	0.30	GM	1,258,607	14,851,275
	P	8129W	Tablet for oral suspension 50mg 10	0.30	GM	80,393	1,082,506
LINCOSAMIDES
J01FF01	CLINDAMYCIN
	A	16644	Capsule 150mg 100	1.20	GM	233	-
	P	3138E	Capsule 150mg	1.20	GM	158,155	5,254,016
	P	5057E	Capsule 150mg	1.20	GM	38,075	730,302
J01FF02	LINCOMYCIN
	P	2530E	Injection 600mg in 2mL	1.80	GM	3,628	133,291
AMINOGLYCOSIDE ANTIBACTERIALS
OTHER AMINOGLYCOSIDES
J01GB03	GENTAMICIN SULPHATE
	P	2824P	Injection 80mg (base) in 2mL	0.24	GM	19,524	391,212
J01GB01	TOBRAMYCIN
	P	1356J	Injection 80mg (base)	0.24	GM	2,204	241,556
	P	5442K	Solution for inhalation 300mg in 5mL 56	0.30	GM	444	958,039
	P	8872Y	Injection 80mg (base) in 2mL (without preserv)	0.24	GM	1,786	234,695
QUINOLONE ANTIBACTERIALS
FLUOROQUINOLONES
J01MA02	CIPROFLOXACIN
	P	1208N	Tablet 250mg	1.00	GM	19,696	741,039
	P	1209P	Tablet 500mg	1.00	GM	155,443	10,036,845
	P	1210Q	Tablet 750mg	1.00	GM	41,891	4,249,645
	A	21046	Tablet 250mg 2	1.00	GM	554	-
J01MA14	MOXIFLOXACIN
	A	20350	Tablet 400mg 5	0.40	GM	7,313	-
J01MA06	NORFLOXACIN
	A	13660	Tablet 400mg 6	0.80	GM	49,459	-
	P	3010K	Tablet 400mg	0.80	GM	230,530	4,602,026
OTHER ANTIBACTERIALS
GLYCOPEPTIDE ANTIBACTERIALS
J01XA01	VANCOMYCIN
	P	2269K	Powder for injection 1gm (1000000iu) 1	2.00	GM	686	25,315
	P	2270L	Powder for injection 1gm (1000000iu) 3	2.00	GM	18,738	924,390
	P	3130R	Injection 500mg (500000iu) (solvent required)	2.00	GM	219	4,585
	P	3131T	Injection 500mg (500000iu) (solvent required)	2.00	GM	7,639	347,918
STEROID ANTIBACTERIALS
J01XC01	FUSIDIC ACID
	P	2312Q	Tablet (sodium salt) 250mg (enteric coated)	1.50	GM	20,488	4,034,300
IMIDAZOLE DERIVATIVES
J01XD01	METRONIDAZOLE
	P	1638F	I.V. infusion 500mg in 100mL	1.50	GM	15,142	434,942
OTHER ANTIBACTERIALS
NITROFURAN DERIVATIVES
J01XE01	NITROFURANTOIN
	P	1692C	Capsule 50mg	0.20	GM	67,317	1,375,796
	P	1693D	Capsule 100mg	0.20	GM	97,626	2,580,472
OTHER ANTIBACTERIALS
J01XX05	HEXAMINE HIPPURATE
	P	3124K	Tablet 1g	2.00	GM	98,389	4,172,489

J02 - ANTIMYCOTICS FOR SYSTEMIC USE
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE IMIDAZOLE DERIVATIVES
J02AB02	KETOCONAZOLE
	P	1572R	Tablet 200mg	0.20	GM	22,422	965,873
	P	1573T	Tablet 200mg	0.20	GM	29,945	606,042
TRIAZOLE DERIVATIVES
J02AC01	FLUCONAZOLE
	A	14171	Capsule 150mg 1	0.20	GM	5,103	-
	P	1471K	Capsule 50mg 28	0.20	GM	8,380	432,455
	P	1472L	Capsule 100mg 28	0.20	GM	11,978	1,148,705
	P	1474N	Solution for IV infusion 200mg in 100mL 7	0.20	GM	840	266,622
	P	1475P	Capsule 200mg	0.20	GM	14,760	2,843,759
	A	19776	Capsule 150mg 1	0.20	GM	242	-
	A	19901	Capsule 150mg 1	0.20	GM	1,392	-
	A	19919	Capsule 150mg 1	0.20	GM	473	-
	A	20146	Capsule 150mg 1	0.20	GM	315	-
	A	20244	Capsule 150mg 1	0.20	GM	959	-
	A	20490	Capsule 150mg 1	0.20	GM	178	-
	A	20517	Capsule 150mg 1	0.20	GM	756	-
	A	20660	Capsule 150mg 1	0.20	GM	4,249	-
	A	20799	Capsule 150mg 1	0.20	GM	1,734	-
J02AC02	ITRACONAZOLE
	A	14810	Capsule 100mg	0.20	GM	2,975	-
	A	16227	Capsule 100mg 28	0.20	GM	3,495	-
	P	8196J	Capsule 100mg	0.20	GM	7,185	2,273,030
J02AC04	POSACONAZOLE
	P	9360P	Oral suspension 40mg/mL 105, 1	0.80	GM	2,548	6,860,165
J02AC03	VORICONAZOLE
	P	9363T	Tablet 50mg 56	0.40	GM	741	937,022
	P	9364W	Tablet 200mg 56	0.40	GM	3,127	8,650,917

J04 - ANTIMYCOBACTERIALS
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIMYCOBACTERIALS DRUGS FOR TREATMENT OF TUBERCULOSIS ANTIBIOTICS
J04AB04	RIFABUTIN
	P	6195C	Capsule 150mg 120	0.15	GM	152	6,177
J04AB02	RIFAMPICIN
	P	1981G	Capsule 150mg	0.60	GM	1,007	18,677
	P	1982H	Capsule 150mg	0.60	GM	486	14,688
	P	1983J	Capsule 300mg	0.60	GM	1,953	122,192
	P	1984K	Capsule 300mg	0.60	GM	6,682	123,115
	P	8025J	Syrup 100mg per 5mL 60mL	0.60	GM	314	11,915
HYDRAZIDES
J04AC01	ISONIAZID
	P	1554T	Tablet 100mg	0.30	GM	1,912	22,496
DRUGS FOR TREATMENT OF LEPRA
DRUGS FOR TREATMENT OF LEPRA
J04BA02	DAPSONE
	P	1272Y	Tablet 100mg	50.00	MG	3,439	380,868
	P	8801F	Tablet 25mg	50.00	MG	2,364	237,502

J05 - ANTIVIRALS FOR SYSTEMIC USE
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE ANTIVIRALS FOR SYSTEMIC USE DIRECT ACTING ANTIVIRALS NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS
J05AB01	ACICLOVIR
	P	1003T	Tablet 200mg	4.00	GM	5,017	329,258
	P	1007B	Tablets 200mg 90	4.00	GM	30,499	3,571,167
	P	1052J	Tablets 800mg 35	4.00	GM	9,847	1,378,135
	P	8234J	Tablets 800mg 120	4.00	GM	179	70,556
J05AB09	FAMCICLOVIR
	A	19696	Tablet 250mg 14	0.75	GM	129	-
	A	19996	Tablet 500mg 3	0.75	GM	45,335	-
	A	21238	Tablet 500mg 3	0.75	GM	29,107	-
	A	21347	Tablet 500mg 3	0.75	GM	1,374	-
	P	2274Q	Tablet 250mg 20	0.75	GM	16,255	2,167,806
	P	8002E	Tablet 250mg	0.75	GM	60,711	8,405,831
	P	8092X	Tablet 125mg	0.75	GM	7,826	1,032,150
	P	8217L	Tablet 250mg	0.75	GM	83,780	28,955,342
	P	8896F	Tablet 500mg 56	0.75	GM	6,540	2,236,191
	P	8897G	Tablet 500mg 30	0.75	GM	4,103	791,740
J05AB11	VALACICLOVIR
	A	20467	Tablet 1000mg 4	3.00	GM	13,735	-
	P	5480K	Tablet 500mg (as hydrochloride) 30	3.00	GM	104,930	17,533,761
	P	8064K	Tablet 500mg 42	3.00	GM	42,891	9,159,804
	P	8133C	Tablet 500mg 20	3.00	GM	16,952	1,790,019
	P	8134D	Tablet 500mg 30	3.00	GM	269,995	44,680,140
J05AB14	VALGANCICLOVIR
	P	6357N	Tablet 450mg (base) 120	0.90	GM	157	490,270
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AF08	ADEFOVIR DIPIVOXIL
	P	6450L	Tablet 30mg 60	10.00	MG	2,103	2,496,121
J05AF02	DIDANOSINE
	P	6300N	Capsule 250mg (enteric coated beads) 60	0.40	GM	211	-
J05AF10	ENTECAVIR
	P	9602J	Tablet 0.5mg 60	0.50	MG	12,115	9,308,463
	P	9603K	Tablet 1mg 60	0.50	MG	1,920	2,335,174
J05AF05	LAMIVUDINE
	P	6193Y	Tablet 150mg 120	0.30	GM	333	134,940
	P	6257H	Tablet 100mg 56	0.30	GM	4,237	1,233,369
	P	6435Q	Tablet 300mg 60	0.30	GM	638	27,932
J05AF04	STAVUDINE
	P	6190T	Capsule 40mg 120	80.00	MG	207	-
J05AF07	TENOFOVIR
	P	6358P	Tablet containing tenofovir disoproxil fumarate 300mg 60	0.25	GM	8,468	8,009,432
J05AF01	ZIDOVUDINE
	P	6154X	Capsule 250mg 240	0.60	GM	183	-
DIRECT ACTING ANTIVIRALS
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AG03	EFAVIRENZ
	P	6356M	Tablet 600mg 60	0.60	GM	121	71,860
J05AG01	NEVIRAPINE
	P	6215D	Tablet 200mg 120	0.40	GM	5,490	2,454,544
NEURAMINIDASE INHIBITORS
J05AH02	OSELTAMIVIR
	A	17034	Capsule 75mg 10	-	-	42,756	-
	A	20830	Capsule 30mg 10	0.15	GM	127	-
J05AH01	ZANAMIVIR
	A	16327	Rotadisk 5mg 20	20.00	MG	3,818	-
ANTIVIRALS FOR TREATMENT OF HIV INFECTION, COMBINATIONS
J05AR	LOPINAVIR with RITONAVIR
	P	6495W	Tablet 200mg-50mg 240	-	-	4,789	5,555,288
J05AR03	TENOFOVIR with EMTRICITABINE
	P	6468K	Tablet containing tenofovir disoproxil fumarate 300mg with emtricitabine 200mg 60	-	-	225	280,123
J05AR06	TENOFOVIR with EMTRICITABINE and EFAVIRENZ
	P	9650X	Tablet containing tenofovir disoproxil fumarate 300mg with emtricitabine 200mg and efavirenz 600mg 60	-	-	217	476,461
J05AR01	ZIDOVUDINE and LAMIVUDINE
	P	6234D	Tablet 150mg-300mg 120	-	-	1,594	1,160,527
J05AR04	ZIDOVUDINE with LAMIVUDINE with ABACAVIR
	P	6327B	Tablet 300mg-150mg-300mg (as sulfate) 120	-	-	530	-

J07 - VACCINES
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE VACCINES BACTERIAL VACCINES CHOLERA VACCINES
J07AE01	CHOLERA
	A	20362	Oral granules inactivated choleme 2	-	-	27,194	-
J07AE02	CHOLERA, LIVE ATTENUATED
	A	18382	Oral granules Cholera, inactivated 14	-	-	21,849	-
MENINGOCOCCAL VACCINES
J07AH04	MENINGOCOCCAL
	A	14507	Vial 0.5mL 1	-	-	7,189	-
	A	15130	Vial 0.5mL 1	-	-	223	-
J07AH07	MENINGOCOCCAL C
	A	17637	Syringe 10ug per 0.5mL conjugated 1	-	-	510	-
PERTUSSIS VACCINES
J07AJ52	DIPHTERIA with TETANUS with PERTUSSIS PURIFIED ANTIGEN
	A	17092	Injection 0.5mL 1	-	-	86,387	-
J07AJ51	DIPHTHERIA, TETANUS and PERTUSSIS VACCINE, ADSORBED
	A	19778	Injection 0.5mL	-	-	17,112	-
PNEUMOCOCCAL VACCINES
J07AL01	PNEUMOCOCCAL
	P	1903E	Injection 0.5mL (23 valent)	-	-	13,339	611,310
TETANUS VACCINES
J07AM51	TETANUS TOXOID, COMBINATIONS with DIPTHERIA
	P	3463G	Injection 0.5mL in pre-filled syringe	-	-	25,705	5,540,788
	P	8783G	Injection 0.5mL in pre-filled syringe	-	-	7,129	448,393
TYPHOID,VACCINES
J07AP01	SALMONELLA-TYPHI
	A	19176	Oral live attenuated capsule Typhoid	-	-	9,097	-
J07AP01	TYPHOID ORAL LIVE ATTENUATED
	A	13158	Cap-ec 3 1	-	-	150	-
J07AP03	TYPHOID PURIFIED POLYSACCHARIDE ANTIGEN
	A	14718	Syringe 0.5mL	-	-	137,341	-
	A	16719	Injection 25ug	-	-	23,659	-
VIRAL VACCINES
ENCEPHALITIS VACCINES
J07BA02	JAPANESE ENCEPHALITIS VACCINE
	A	20716	Pre-filled syringe 0.5mL	-	-	436	-
INFLUENZA VACCINES
J07BB02	INFLUENZA VACCINE
	A	20292	Injection 0.5mL	-	-	1,231	-
	A	20834	Injection 0.1mL	-	-	8,703	-
	A	21010	Injection (trivalent) 0.5mL	-	-	147,561	-
	A	21012	Injection (trivalent) 0.5mL	-	-	121,930	-
	A	21013	Injection (trivalent) 0.5mL	-	-	9,027	-
	A	21473	Pre-filled syringe 0.5mL 1	-	-	2,085	-
VIRAL VACCINES
HEPATITIS VACCINES
J07BC02	HEPATITIS A
	A	15677	Syringe 720u/0.5mL	-	-	28,418	-
	A	15687	Syringe 144u 1	-	-	98,639	-
	A	15770	Syringe 25u 1	-	-	381	-
	A	17617	Vial 0.5mL 1	-	-	321	-
J07BC20	HEPATITIS A\HEPATITIS B
	A	15760	Syringe 1mL	-	-	107,763	-
	A	15917	Syringe 0.5mL	-	-	2,175	-
	A	17055	Syringe 0.5mL	-	-	6,835	-
J07BC01	HEPATITIS B
	A	13026	Ampoule 20ug per mL 1	-	-	67,965	-
	A	13473	Ampoule 10ug per 0.5mL 1	-	-	1,577	-
	A	20760	Pre-filled syringe 20ug per mL 1	-	-	19,830	-
	A	20833	Pre-filled syringe 10ug per 0.5mL 1	-	-	505	-
J07BC20	SALMONELLA and HEPATITIS A
	A	17818	Prefilled syringe 25ug and 160 Elisa units	-	-	80,159	-
MEASLES VACCINES
J07BD52	MEASLES with MUMPS with RUBELLA
	A	18509	Injection 0.5mL 1	-	-	12,044	-
POLIOMYELITIS VACCINES
J07BF03	POLIOMYELITIS
	A	16235	Injection 0.5mL	-	-	8,066	-
RABIES VACCINES
J07BG01	RABIES INACTIVATED
	A	14107	Injection 1mL 1	-	-	4,738	-
	A	19166	Injection 2.5ug 1	-	-	6,207	-
VARICELLA VACCINES
J07BK01	VARICELLA LIVE ATTENUATED
	A	16723	Vaccine 0.5mL	-	-	9,947	-
PAPILLOMAVIRUS VACCINES
J07BM02	VACCINE PAPILLOMAVIRUS (HUMAN TYPES 16 and 18)
	A	20142	Injection 0.5mL prefilled syringe 1	-	-	615	-
J07BM01	VACCINE PAPILLOMAVIRUS (HUMAN TYPES 6, 11, 16 and 18)
	A	10756	Injection 0.5mL prefilled syringe 1	-	-	12,064	-
BACTERIAL AND VIRAL VACCINES, COMBINED
BACTERIAL AND VIRAL VACCINES, COMBINED
J07CA02	DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
	A	18391	Injection 0.5mL 1	-	-	209	-
	A	19175	Injection 0.5mL, 1	-	-	30,759	-
	A	20236	Injection 0.5mL syringe	-	-	4,060	-

Australian Statistics on Medicines 2011

Table 1 - Generic Antiinfectives for Systemic Use

Department of Health and Aged Care

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry